VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,122 | -10.6% | 2,346 | 0.0% | 0.02% | -5.9% |
| Q2 2023 | $70,628 | -6.9% | 2,346 | 0.0% | 0.02% | -10.5% |
| Q1 2023 | $75,882 | +12.9% | 2,346 | 0.0% | 0.02% | +5.6% |
| Q4 2022 | $67,227 | +17.9% | 2,346 | -1.3% | 0.02% | +5.9% |
| Q3 2022 | $57,000 | -10.9% | 2,378 | +1.5% | 0.02% | -10.5% |
| Q2 2022 | $64,000 | -28.1% | 2,344 | 0.0% | 0.02% | -13.6% |
| Q1 2022 | $89,000 | +20.3% | 2,344 | 0.0% | 0.02% | +22.2% |
| Q4 2021 | $74,000 | +7.2% | 2,344 | +0.0% | 0.02% | 0.0% |
| Q3 2021 | $69,000 | -12.7% | 2,343 | 0.0% | 0.02% | -10.0% |
| Q2 2021 | $79,000 | +3.9% | 2,343 | 0.0% | 0.02% | -4.8% |
| Q1 2021 | $76,000 | -3.8% | 2,343 | +3.5% | 0.02% | -4.5% |
| Q4 2020 | $79,000 | – | 2,263 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |